NewsBenzinga허치메드, 일요일 ESMO에서 발표···SAFFRON 3상, MET 기반 EGFR 변이 폐암에서 오파티스 플러스 타그리소가 화학요법 대비 진행 또는 사망 위험 45%, 사망 위험 32% 감소 효과 나타내 허치메드, 일요일 ESMO에서 발표···SAFFRON 3상, MET 기반 EGFR 변이 폐암에서 오파티스 플러스 타그리소가 화학요법 대비 진행 또는 사망 위험 45%, 사망 위험 32% 감소 효과 나타내 Benzinga 2026.10.26 06:19 (GMT+0) Open on Benzinga Other news Honeywell Technologies Debuts Forge Plant Cognition At Dangote’s Lekki Refinery, Estimating More Than 29 Cents A Barrel In Operational Benefit, Or Over $60M Per Year At Full Capacity Trader Mk4's NEAR long shows $12.15M unrealized profit, long position worth over $25M Baron Health Care Fund Q3 2026 Top Contributors And Detractors Sturm, Ruger: Strategic Alliance With Beretta Supports Long-Term Growth (NYSE:RGR) Robert Reich Says Elon Musk’s SpaceX and Starlink Should Become Publicly Owned, Musk Fires Back: ‘Stealing Companies Is a Serious Crime' Bristol Myers Squibb, SystImmune’s Iza-Bren Hits Primary Endpoint In Phase 3 PANKU-Lung01 Interim Analysis, Median PFS 11.1 Versus 5.7 Months (HR 0.40) Over Platinum Chemotherapy In EGFR-Mutated NSCLC
Honeywell Technologies Debuts Forge Plant Cognition At Dangote’s Lekki Refinery, Estimating More Than 29 Cents A Barrel In Operational Benefit, Or Over $60M Per Year At Full Capacity
Robert Reich Says Elon Musk’s SpaceX and Starlink Should Become Publicly Owned, Musk Fires Back: ‘Stealing Companies Is a Serious Crime'
Bristol Myers Squibb, SystImmune’s Iza-Bren Hits Primary Endpoint In Phase 3 PANKU-Lung01 Interim Analysis, Median PFS 11.1 Versus 5.7 Months (HR 0.40) Over Platinum Chemotherapy In EGFR-Mutated NSCLC
